Back to search

Peptide record

TPDB19604

Antibacterial Anticancer Toxicity standard
17 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB19604
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia CancerPPD 2.0
standard
No
A 17-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia and CancerPPD 2.0, with an available 3D structural model.
Sequence
FWRIRIRRPRRIRIRWF
Physicochemical Analysis
C117H187N43O18
ANDCEQGHLKMSTYV
R
2484.05
13.25
8
0
8
+8
-0.27
-0.929
91.76
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
11000
442.83
0
Residue Composition
number
0
A
8
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
4
I
0
L
0
K
0
M
2
F
1
P
0
S
0
T
2
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 8 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 4 L: 0 K: 0 M: 0 F: 2 P: 1 S: 0 T: 0 W: 2 Y: 0 V: 0
Chemical Descriptors
17
C117H187N43O18
2484.05
13.25
+8
-0.27
-0.929
Evidence Records 3 records
Evidence 1 Activity

Activity

LC50
Toxicity
68.2±0.2 µM
Cytotoxic
LC50 | 68.2±0.2 | µM | target cell: Human dermal fibroblasts

Target

Human dermal fibroblasts

Source & Reference

NA
DBAASP
Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies. | Biochim Biophys Acta | 2020
Evidence 2 Activity

Activity

LC50
Toxicity
31.8±1.0 µM
Cytotoxic
LC50 | 31.8±1.0 | µM | target cell: Human epidermal melanocytes

Target

Human epidermal melanocytes

Source & Reference

NA
DBAASP
Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies. | Biochim Biophys Acta | 2020
Evidence 3 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochim Biophys Acta Biomembr. 2020 Aug 1 1862(8):183264.